TP 53-based interaction analysis identifies cis-eQTL variants for TP 53 BP 2 , FBXO 28 , and FAM 53 A that associate with survival and treatment outcome in breast cancer
暂无分享,去创建一个
P. Fasching | K. Czene | P. Hall | H. Brenner | Sofia Khan | E. Provenzano | D. Lambrechts | A. Dunning | G. Chenevix-Trench | H. Nevanlinna | Jianjun Liu | U. Hamann | A. Mannermaa | V. Kosma | A. Lindblom | K. Michailidou | M. Schmidt | M. Bolla | K. Aittomäki | C. Blomqvist | I. Andrulis | M. Hooning | A. Jager | M. Lush | P. Heikkilä | Hallberg | M. Kabisch | H. Ali | B. Holleczek | Qi Guo | Qin | Keeman | L. John | Hopper | P. Hall